Evidence map›Paper›PMID 15111544›Full record

ArticleDiabetes care2004

Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population.

Jeannet Lauenborg, Torben Hansen, Dorte Møller Jensen, Henrik Vestergaard, Lars Mølsted-Pedersen, Peter Hornnes, Henning Locht, Oluf Pedersen, Peter Damm

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01795248 (The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus), which is not on this map. Cited by 92 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 5 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01795248 phase4completedstarted 2012, after this paper: background citation

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus

Ran2012Enrolled105Registered outcomes18Posted comparisons0ConditionsGestational Diabetes MellitusArmsliraglutide, Placebo
PMID 19853906PMID 21844879PMID 20682697PMID 10702749PMID 10842653PMID 11776065PMID 12027921PMID 14634573PMID 14968296PMID 16009062PMID 17928588PMID 21153530other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 5 syntheses or guidelines pooled it, 258 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jeannet LauenborgDepartment of Obstetrics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. jeannet@lauenb.org
Torben Hansen
Dorte Møller Jensen
Henrik Vestergaard
Lars Mølsted-Pedersen
Peter Hornnes
Henning Locht
Oluf Pedersen
Peter Damm
Copenhagen University Hospital · DKSteno Diabetes Center · DKGlostrup Hospital · DKHerlev Hospital · DKOdense University Hospital · DKRigshospitalet · DKStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the incidence of diabetes among women with previous diet-treated gestational diabetes mellitus (GDM) in the light of the general increasing incidence of overweight and diabetes and to identify risk factors for the development of diabetes. RESEARCH DESIGN AND

methodsWomen with diet-treated GDM during 1978-1985 (old cohort, n = 241, also followed up around 1990) or 1987-1996 (new cohort, n = 512) were examined in 2000-2002. Women were classified by a 2-h, 75-g oral glucose tolerance test according to the World Health Organization criteria or an intravenous glucagon test supplemented by measurement of GAD antibodies. Historical data from index-pregnancy and anthropometrical measurements were collected.

resultsA total of 481 (63.9%) women were examined (median 9.8 years [interquartile range 6.4-17.2]) after index pregnancy. Diabetes and impaired glucose tolerance (IGT)/impaired fasting glucose were present in 40.0 and 27.0% of women, respectively. In the new cohort, 40.9% had diabetes compared with 18.3% in the old cohort at the 1990 follow-up (P < 0.0005). Prepregnancy BMI was significantly higher in the new compared with the old cohort (26.0 [22.5-30.8] vs. 22.9 kg/m2 [20.2-28.0], P < 0.0005). Among others, new-cohort membership, prepregnancy overweight (BMI > or = 25 kg/m2), and IGT postpartum were identified as independent predictors of diabetes by multiple logistic regression analyses.

conclusionsThe incidence of diabetes among Danish women with previous diet-treated GDM was very high and had more than doubled over a 10-year period. This seems to be due to a substantial increase in BMI in women with GDM.

Indexed as

AdultBody Mass IndexCohort StudiesDenmarkDiabetes, GestationalDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleFollow-Up StudiesGestational AgeGlucagonGlucose Tolerance TestHumansIncidenceInfant, NewbornGlucagon

Identifiers

PMID15111544
OpenAlexW2128410589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.